(Updates to reflect Mitsui's company release dated Sept. 11)
Mitsui & Co (TYO:8031) is establishing a medical data network across Asia under an agreement with Singapore's Oncoshot, according to a Sept. 11 company release.
The deal will see Mitsui use Oncoshot's proprietary clinical data analysis technology, as the companies aim to promote the standardization of oncology clinical data, advance international research, shorten clinical study timelines, and generate evidence based on diverse patient populations, the release said.
Working with Singapore-based startup Oncoshot and leveraging its hospital network stake, Mitsui has launched the platform with roughly 100,000 patient records across more than 20 facilities, according to a Nikkei report on Thursday.
The company is also in talks with major Japanese institutions to join by 2028, the report said.
